SCHNEYER MARK C. (Chief Financial Officer) sold 35.4% of their position (22K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $554.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/19/2025ACC: 0001415889-25-022359
Officer· Chief Financial Officer
Since Dec 2021
-22K
Net shares
Net seller
$554.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
22K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−22K
Price / share
$25.18
Trade value
$554.02K
% of position
35.4%
8/18/2025
62.13K→40.13K
Total
Net shares
−22K
Net value
-$554.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2025 | S · Sale | −22K | $25.18 | $554.02K | 35.4% | 62.13K | 40.13K |
| Total | −22K | -$554.02K | ||||||
Derivative Transactions0
No derivative transactions reported